Monday, January 25, 2021
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Articles
    • See All Articles
    • NEW: COVID-Related
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
  • Events
    • Webinars & Events
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Articles
    • See All Articles
    • NEW: COVID-Related
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
  • Events
    • Webinars & Events
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
Corporate Compliance Insights
Home Compliance

DOJ Collects Millions in Two High-Profile False Claims Act Cases

Duke University and MedStar Health Reach Settlements

by Michael Volkov
April 18, 2019
in Compliance, Featured
duke university chapel in Durham, NC

Michael Volkov sheds light on recent False Claims Act cases brought against Duke University and MedStar Health – both with violations spanning multiple years.

Companies that depend on federal funding (e.g., health care, government contractors and university researchers) face significant risks for False Claims Act prosecutions. Relying on pro-government False Claims Act statutes, potential whistleblowers can earn enormous judgments by filing private actions under seal and seeking federal government intervention in the matter to prosecute False Claims Act violations. In those cases where the federal government agrees to intervene, it almost always wins the case or reaches a favorable settlement. 

In two recent examples, the DOJ collected $112.5 million from Duke University for False Claims Act violations related to scientific research misconduct and $35 million from MedStar Health for illegal kickbacks to a cardiology group in exchange for patient referrals.

Duke University

In the Duke University case, the DOJ brought a False Claims Act action based on issued raised by a whistleblower. Specifically, the DOJ alleged that from 2006 to 2018, Duke submitted grant applications and progress reports that contained falsified research on federal grants to the National Institutes of Health (NIH) and the Environmental Protection Agency (EPA).

The whistleblower received a recovery of $33.7 million.

The government alleged that Duke submitted false or fabricated data or statements to the NIH and EPA involving 30 grants, causing the NIH and EPA to pay out grant funds. The false research data and statements was related to certain research involving mice conducted by a Duke research technician in its Airway Physiology Laboratory.

MedStar Health

In the MedStar Health case, MedStar agreed to pay $35 million to settle allegations that MedStar paid kickbacks to MidAtlantic Cardiovascular Associates (MACVA), a cardiology group based in Maryland, in exchange for referrals through a series of professional services contracts at two Baltimore hospitals.

The MedStar settlement focused on two distinct schemes: first, during the period from 2006 to 2011, MACVA was paid kickbacks under the guise of a professional services contract in return for patient referrals for lucrative cardiovascular procedures, including cardiac surgery and interventional cardiology procedures; and second, from 2006 to 2012, Medicare payments were received by MedStar for medically unnecessary stents performed by a onetime employee of MACVA who was later employed by MedStar.

The MedStar matter was initiated by three whistleblowers who were members of Cardiac Surgery Associates in Baltimore, and in the second matter, by former patients who received heart stents from a heart surgeon and alleged that the surgeon and one of the Baltimore hospitals engaged in a pattern and practice of performing medically unnecessary stent placement procedures.

Under the settlements announced by the DOJ, the whistleblowers received an undisclosed portion of the federal share of recovery.

This article was republished with permission from Michael Volkov’s blog, Corruption, Crime & Compliance.


Tags: false claims actwhistleblowing
Previous Post

Are You a Board-Ready Executive? Take These 10 Steps First

Next Post

Compliance Program Evolution: The Need for a Compliance Management System

Michael Volkov

Michael-Volkov-leclairryan Michael Volkov is the CEO of The Volkov Law Group LLC, where he provides compliance, internal investigation and white collar defense services.  He can be reached at mvolkov@volkovlaw.com. Michael has extensive experience representing clients on matters involving the Foreign Corrupt Practices Act, the UK Bribery Act, money laundering, Office of Foreign Asset Control (OFAC), export controls, sanctions and International Traffic in Arms, False Claims Act, Congressional investigations, online gambling and regulatory enforcement issues. Michael served for more than 17 years as a federal prosecutor in the U.S. Attorney’s Office in the District of Columbia; for five years as the Chief Crime and Terrorism Counsel for the Senate Judiciary Committee, and Chief Crime, Terrorism and Homeland Security Counsel for the Senate and House Judiciary Committees; and as a Trial Attorney in the Antitrust Division of the U.S. Department of Justice. Michael also maintains a well-known blog: Corruption Crime & Compliance, which is frequently cited by anti-corruption professionals and professionals in the compliance industry.

Related Posts

illustration of mafia man in silhouette with red tie

The Mafia’s Jackpot: How Criminal Organizations are Profiting from COVID-19

January 22, 2021
illustration of videoconference, screen and speech bubbles

New Risks as COVID-19 Forces Rapid Technology Adoption

January 21, 2021
silhouette of businesspeople in meeting with blue cyber background

Cyber Risk Quantification and Prioritization is the Future of GRC

January 20, 2021
miniature airplane on global currency

FinCEN’s Proposed Changes to the Recordkeeping and Travel Rule Thresholds

January 20, 2021
Next Post
concept of human evolution against starry background

Compliance Program Evolution: The Need for a Compliance Management System

Access realtime data
Dynamic Risk Assessments with Workiva

Special Coverage

Special COVID page graphic

Jump to a Topic:

anti-corruption anti-money laundering/AML Artificial Intelligence/A.I. automation banks board of directors board risk oversight bribery CCPA/California Consumer Privacy Act Cloud Compliance communications management Coronavirus/COVID-19 corporate culture crisis management cyber crime cyber risk data analytics data breach data governance decision-making diversity DOJ due diligence fcpa enforcement actions financial crime GDPR GRC HIPAA information security internal audit KYC/know your customer machine learning monitoring ransomware regtech reputation risk risk assessment Sanctions SEC social media risk technology third party risk management tone at the top training whistleblowing
No Result
View All Result

Privacy Policy

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • RSS Feed

Category

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • Opinion
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Whitepapers

© 2019 Corporate Compliance Insights

No Result
View All Result
  • Home
  • About
  • Articles
  • Vendor News
  • Podcasts
  • Videos
  • Whitepapers
  • eBooks
  • Events
  • Jobs
  • Subscribe

© 2019 Corporate Compliance Insights